Haemodialysis significantly reduces serum levetiracetam levels inducing epileptic seizures: Case report.
作者： M. J. Company-Albir , J. Ruíz-Ramos , A. Solana Altabella , M. R. Marqués-Miñana , C. Vicent
DOI: 10.1111/JCPT.12568
关键词:
摘要: SummaryWhat is known and objective Levetiracetam used in the treatment of some forms epilepsy. In renal impairment patients on chronic haemodialysis, dose adjustment required. We report a case. Case description This case describes woman levetiracetam who presented with generalized tonic-clonic seizures during haemodialysis session. impact dialysis levels. What new conclusion Haemodialysis reduces serum concentration can lead to subtherapeutic levels. Close monitoring necessary when receiving anticonvulsant drugs that are extensively eliminated by procedure.
sci-hub.se 参考文章(11)
P.N. Patsalos, Pharmacokinetic profile of levetiracetam: toward ideal characteristics. Pharmacology & Therapeutics. ,vol. 85, pp. 77- 85 ,(2000) , 10.1016/S0163-7258(99)00052-2
Scott D. Nei, Erica D. Wittwer, Kianoush B. Kashani, Erin N. Frazee, Levetiracetam Pharmacokinetics in a Patient Receiving Continuous Venovenous Hemofiltration and Venoarterial Extracorporeal Membrane Oxygenation Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. ,vol. 35, pp. e127- e130 ,(2015) , 10.1002/PHAR.1615
Gaetano Zaccara, Andrea Messori, Flavio Moroni, Clinical Pharmacokinetics of Valproic Acid — 1988 Clinical Pharmacokinectics. ,vol. 15, pp. 367- 389 ,(1988) , 10.2165/00003088-198815060-00002
Amar D. Bansal, Chloe E. Hill, Jeffrey S. Berns, Use of Antiepileptic Drugs in Patients with Chronic Kidney Disease and End Stage Renal Disease Seminars in Dialysis. ,vol. 28, pp. 404- 412 ,(2015) , 10.1111/SDI.12385
Philip N Patsalos, Clinical pharmacokinetics of levetiracetam Clinical Pharmacokinectics. ,vol. 43, pp. 707- 724 ,(2004) , 10.2165/00003088-200443110-00002
Jacqueline French, Use of levetiracetam in special populations. Epilepsia. ,vol. 42, pp. 40- 43 ,(2001) , 10.1111/J.1528-1167.2001.00009.X
Junichi Yamamoto, Nathalie Toublanc, Yuji Kumagai, Armel Stockis, Levetiracetam Pharmacokinetics in Japanese Subjects with Renal Impairment Clinical Drug Investigation. ,vol. 34, pp. 819- 828 ,(2014) , 10.1007/S40261-014-0237-7
Frédérique Lancelin, Emilie Franchon, Linda Kraoul, Isabelle Garciau, Sophie Brovedani, Khalid Tabaouti, Elisabeth Landré, Francine Chassoux, Pascal Paubel, Marie-Liesse Piketty, Therapeutic drug monitoring of levetiracetam by high-performance liquid chromatography with photodiode array ultraviolet detection: preliminary observations on correlation between plasma concentration and clinical response in patients with refractory epilepsy. Therapeutic Drug Monitoring. ,vol. 29, pp. 576- 583 ,(2007) , 10.1097/FTD.0B013E318157032D
Emília Maria Dantas Soeiro, Claudia Maria de Barros Helou, Clinical, pathophysiological and genetic aspects of inherited tubular disorders in childhood. Jornal Brasileiro De Nefrologia. ,vol. 37, pp. 385- 398 ,(2015) , 10.5935/0101-2800.20150060
Andrea M. New, Scott D. Nei, Kianoush B. Kashani, Alejandro A. Rabinstein, Erin N. Frazee, Levetiracetam Pharmacokinetics During Continuous Venovenous Hemofiltration and Acute Liver Dysfunction Neurocritical Care. ,vol. 25, pp. 141- 144 ,(2016) , 10.1007/S12028-016-0242-1